• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Tumor Biology Eventually Prevails in the Optimal Treatment of Perihilar Cholangiocarcinoma.

作者信息

Cheung Dillon, Stucky Chee-Chee, Fong Zhi Ven

机构信息

Division of Surgical Oncology and Endocrine Surgery, Department of Surgery, Mayo Clinic Arizona, Phoenix, AZ, USA.

出版信息

Ann Surg Oncol. 2024 Oct;31(10):6350-6351. doi: 10.1245/s10434-024-15868-8. Epub 2024 Jul 20.

DOI:10.1245/s10434-024-15868-8
PMID:39031262
Abstract
摘要

相似文献

1
Tumor Biology Eventually Prevails in the Optimal Treatment of Perihilar Cholangiocarcinoma.肿瘤生物学最终在肝门部胆管癌的最佳治疗中占主导地位。
Ann Surg Oncol. 2024 Oct;31(10):6350-6351. doi: 10.1245/s10434-024-15868-8. Epub 2024 Jul 20.
2
Liver transplantation for intrahepatic and perihilar cholangiocarcinoma: Current and future.肝内和肝门周围胆管癌的肝移植：现状与未来
Hepatobiliary Pancreat Dis Int. 2020 Apr;19(2):101-102. doi: 10.1016/j.hbpd.2020.02.008. Epub 2020 Feb 28.
3
For a clearer comprehension of the lymphatic system in perihilar cholangiocarcinoma.
Am J Surg. 2016 Feb;211(2):493. doi: 10.1016/j.amjsurg.2015.07.014. Epub 2015 Oct 21.
4
Accepting Our Technical Limitations: Intraoperative Bile Duct Margin in Perihilar Cholangiocarcinoma Reflects Disease Biology.正视我们的技术局限：肝门部胆管癌术中胆管切缘反映疾病生物学特性
Ann Surg Oncol. 2023 Jun;30(6):3180-3181. doi: 10.1245/s10434-023-13200-4. Epub 2023 Feb 3.
5
Surgery for perihilar cholangiocarcinoma.肝门部胆管癌手术
Br J Surg. 2018 Jun;105(7):771-772. doi: 10.1002/bjs.10875.
6
ASO Author Reflections: Surgical Strategy for Perihilar Cholangiocarcinoma.《美国外科医师学会（ASO）作者反思：肝门部胆管癌的手术策略》
Ann Surg Oncol. 2024 Jul;31(7):4454-4455. doi: 10.1245/s10434-024-15156-5. Epub 2024 Mar 6.
7
Major Hepatectomy for Perihilar Cholangiocarcinoma: Taking Sides.肝门部胆管癌的扩大肝切除术：支持哪一方。
Ann Surg Oncol. 2024 Jul;31(7):4169-4172. doi: 10.1245/s10434-024-15211-1. Epub 2024 Mar 22.
8
Extended Right-hemihepatectomy Is Preferred for Perihilar Cholangiocarcinoma.肝门部胆管癌首选扩大右半肝切除术。
Ann Surg. 2021 Jul 1;274(1):33-34. doi: 10.1097/SLA.0000000000004821.
9
Cystic duct carcinoma and type I/II perihilar cholangiocarcinoma: Clinicopathological features and a new differential diagnosis model.胆囊管癌与I/II型肝门周围胆管癌：临床病理特征及一种新的鉴别诊断模型
Eur J Surg Oncol. 2023 Dec;49(12):107099. doi: 10.1016/j.ejso.2023.107099. Epub 2023 Sep 26.
10
ASO Author Reflections: Adequate Nodal Classification for Perihilar Cholangiocarcinoma.ASO作者反思：肝门周围胆管癌的充分淋巴结分类
Ann Surg Oncol. 2023 Jul;30(7):4318-4319. doi: 10.1245/s10434-023-13418-2. Epub 2023 Mar 31.

本文引用的文献

1
ASO Author Reflections: Palliative Therapy Might be an Alternative When the Risks of Surgery for Perihilar Cholangiocarcinoma are High.ASO作者反思：当肝门部胆管癌手术风险较高时，姑息治疗可能是一种替代方案。
Ann Surg Oncol. 2024 Oct;31(10):6569-6570. doi: 10.1245/s10434-024-15830-8. Epub 2024 Jul 16.
2
Reappraising the Role of Intraoperative Neck Margin Revision in Post-Neoadjuvant Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: A Multi-Institutional Analysis.重新评估术中颈部切缘修正术在新辅助治疗后胰腺导管腺癌胰十二指肠切除术中的作用：一项多机构分析
Ann Surg. 2024 May 6. doi: 10.1097/SLA.0000000000006322.
3
The rise of biliary tract cancers and next-generation population registries.
Cancer. 2024 Jul 1;130(13):2257-2259. doi: 10.1002/cncr.35284. Epub 2024 Mar 19.
4
Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer.度伐利尤单抗联合吉西他滨和顺铂治疗晚期胆道癌。
NEJM Evid. 2022 Aug;1(8):EVIDoa2200015. doi: 10.1056/EVIDoa2200015. Epub 2022 Jun 1.
5
How to Determine Unresectability in Hilar Cholangiocarcinoma.如何判定肝门部胆管癌的不可切除性
Surg Clin North Am. 2024 Feb;104(1):197-214. doi: 10.1016/j.suc.2023.09.001. Epub 2023 Sep 27.
6
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial.帕博利珠单抗联合吉西他滨和顺铂与单纯吉西他滨和顺铂治疗晚期胆道癌患者的比较（KEYNOTE-966）：一项随机、双盲、安慰剂对照、3 期临床试验。
Lancet. 2023 Jun 3;401(10391):1853-1865. doi: 10.1016/S0140-6736(23)00727-4. Epub 2023 Apr 16.
7
The Clinical Management of Cholangiocarcinoma in the United States and Europe: A Comprehensive and Evidence-Based Comparison of Guidelines.美国和欧洲胆管癌的临床管理：指南的全面循证比较
Ann Surg Oncol. 2021 May;28(5):2660-2674. doi: 10.1245/s10434-021-09671-y. Epub 2021 Mar 1.
8
Morbidity and mortality after major liver resection in patients with perihilar cholangiocarcinoma: A systematic review and meta-analysis.肝门部胆管癌患者行大肝切除术后的发病率和死亡率：系统评价和荟萃分析。
Surgery. 2019 May;165(5):918-928. doi: 10.1016/j.surg.2019.01.010. Epub 2019 Mar 11.
9
Value of intraoperative neck margin analysis during Whipple for pancreatic adenocarcinoma: a multicenter analysis of 1399 patients.胰十二指肠切除术治疗胰腺腺癌时术中切缘分析的价值：1399例患者的多中心分析
Ann Surg. 2014 Sep;260(3):494-501; discussion 501-3. doi: 10.1097/SLA.0000000000000890.
10
Basic principles in surgical oncology.外科肿瘤学的基本原则。
Arch Surg. 1997 Apr;132(4):338-46. doi: 10.1001/archsurg.1997.01430280012001.